ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.085 | -3.66379310345 | 2.32 | 2.6 | 2.18 | 395817 | 2.28018839 | CS |
4 | -0.425 | -15.977443609 | 2.66 | 2.82 | 2.18 | 339385 | 2.47288606 | CS |
12 | -1.215 | -35.2173913043 | 3.45 | 4.21 | 2.18 | 516994 | 3.19145158 | CS |
26 | 0.455 | 25.5617977528 | 1.78 | 4.62 | 1.65 | 860088 | 3.64475594 | CS |
52 | 0.395 | 21.4673913043 | 1.84 | 4.62 | 1.61 | 512047 | 3.39336962 | CS |
156 | -2.6195 | -53.9602430734 | 4.8545 | 6.15 | 0.53 | 831257 | 2.25192677 | CS |
260 | -6.305 | -73.8290398126 | 8.54 | 9.46 | 0.53 | 804766 | 4.24347014 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.